Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
Anti-Cancer Drugs|August 13, 2021
Differential prognostic impact of complete blood count-related parameters by prior use of novel androgen receptor pathway inhibitors in docetaxel-treated castration-resistant prostate cancer patientsHiroki Kobayashi, Masaki Shiota, Nobuaki Sato, et al.
Japanese Journal of Clinical Oncology|February 23, 2021
Prognostic impact of prior local therapy in castration-resistant prostate cancerMikifumi Koura, Masaki Shiota, Shohei Ueda, et al.
Anticancer Research|November 4, 2021
Prognostic Value of Lower Tract Urinary Symptoms in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Kosuke Ieiri, Masaki Shiota, et al.
Transplant Immunology|December 21, 2014
Renal cancer treatment with recipient lymphocyte infusion enhanced the antitumor effect of nonmyeloablative allogeneic stem cell transplantationArio Takeuchi, Masatoshi Eto, Katsunori Tatsugami, et al.
Cancer Immunology, Immunotherapy : CII|August 11, 2021
Effect of HLA genotype on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle-invasive bladder cancerMizuki Kobayashi, Nobuhiro Fujiyama, Tokiyoshi Tanegashima, et al.
Cancer Research|March 16, 2013
Hsp27 regulates epithelial mesenchymal transition, metastasis, and circulating tumor cells in prostate cancerMasaki Shiota, Jennifer L Bishop, Ka Mun Nip, et al.
Urologic Oncology|July 3, 2021
The impact of single-nucleotide polymorphisms on intravesical recurrence after bacillus Calmette-Guérin therapy for non-muscle invasive bladder cancer in a genome-wide association studyShohei Nagakawa, Masaki Shiota, Naohiro Fujimoto, et al.
Cancer Investigation|January 4, 2021
Efficacy and Safety of 4-Weekly Docetaxel for Castration-Resistant Prostate CancerTakuya Yamashita, Masaki Shiota, Asako Machidori, et al.
JMA Journal|February 28, 2022
Anticancer Effect of Second-line Treatment for Castration-Resistant Prostate Cancer Following First-line Treatment with Androgen Receptor Pathway InhibitorsTakashi Matsumoto, Masaki Shiota, Shigetomo Yamada, et al.
Anticancer Research|July 20, 2021
Lactate Dehydrogenase Is a Serum Prognostic Factor in Clinically Regional Lymph Node-positive Prostate CancerLeandro Blas, Masaki Shiota, Shigetomo Yamada, et al.
Pageof 12